Endothelial cell growth factor

Details Endothelial cell growth factor Endothelial cell growth factor

C - Chemistry, Metallurgy

12

N

530/13, 195/1.11

C12N 15/18 (2006.01) A61K 31/70 (2006.01) C07K 1/18 (2006.01) C07K 14/475 (2006.01) C07K 16/22 (2006.01) C12N 5/10 (2006.01) C12P 21/02 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2005600

ABSTRACT Platelet-derived endothelial cell growth factor (PD-ECGF) is a 45 kDa endothelial cell mitogen that has been purified to homogeneity from human platelets. It does not bind to heparin and does not stimulate the proliferation of fibroblasts, in contrast to other endothelial mitogens of the fibroblast growth factor (FGF) family. PD-ECGF appears to be the only endothelial cell growth factor in human platelets and recent data indicate that it has angiogenic activity in vitro, i.e., the ability to stimulate the formation of new blood vessels and chemotactic activity, in vitro. The present invention provides a homogeneous PD-ECGF in substantially greater yields than available in the past, the primary structure of PD-ECGF, antibodies against PD-ECGF, clones of its cDNA, and variants thereof. The invention also provides a therapeutic preparation of PD-ECGF.

Affiliated with

Also associated with

Rating

Endothelial cell growth factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Endothelial cell growth factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelial cell growth factor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1903581